Advances in Neuro-Oncological Imaging (Volume II)
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Methods and Technologies Development".
Deadline for manuscript submissions: 15 October 2024 | Viewed by 85
Special Issue Editors
Interests: neuroimaging; radiomics/radiogenomics in context of brain tumors; MRI; PET; PET/MRI
Special Issues, Collections and Topics in MDPI journals
Interests: neuro-oncology; biomarkers; clinical studies; immunotherapy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We are excited to invite you to contribute to this Special Issue, which is the second edition of "Advances in Neuro-Oncological Imaging" (https://www.mdpi.com/journal/cancers/special_issues/Neuro_Oncological).
Central nervous system tumors have a significant impact on patient quality of life, as well as the healthcare system due to the profound level of impairment that is already evident in the early stage of the disease, posing a tremendous medical and socioeconomic burden. The most widely used method for identifying and monitoring brain and spinal cord tumors is non-invasive imaging techniques on a qualitative or quantitative basis.
This Special Issue of Cancers aims to highlight imaging techniques that can provide new insights into tumor detection, diagnosis, molecular profiling, prognosis or the prediction of response to treatment in primary and secondary CNS tumors.
We are pleased to invite you to submit original research articles and reviews, with a focus on novel aspects of diverse neuro-oncological imaging research fields such as advanced MRI (including hyperpolarized MRI, CEST imaging, MR fingerprinting, quantitative MRI), PET, neuro-oncological imaging biomarkers, radiomics or multi-omic approaches, as well as functional MRI or intraoperative MRI.
We look forward to receiving your contributions.
Dr. Julia Furtner
Dr. Anna Sophie Berghoff
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- central nervous system (CNS) tumors
- brain tumors
- spinal cord tumors
- magnetic resonance imaging (MRI)
- positron emission tomography (PET)
- intraoperative MRI
- imaging biomarkers
- metabolic imaging
- radiomics
- machine learning